Denial management is the organized process practices use to catch, fix, appeal, and ultimately prevent these unpaid or underpaid claims. This article walks through the denial lifecycle, the most common causes, and how prevention actually works — with specific attention to the realities of independent infectious disease practices, where authorization timing, OPAT, and infusion billing add extra layers of risk.
This is written for U.S. infectious disease physicians, group leaders, and practice administrators who want a practical understanding of how denials happen and what to do about them.
Key Takeaways
- Denial management covers recovering today's denied claims and preventing tomorrow's repeat failures
- Root-cause tracking, not just resubmission, is what reduces denial volume over time
- Authorization timing and drug/administration coding drive many ID-specific denials
- Appeal deadlines vary by payer; missing one can turn a recoverable claim into a write-off
- Measuring denials by dollar value, not just count, matters most in drug-heavy specialties
What Is Denial Management in Healthcare?
Denial management is the structured work of identifying, categorizing, correcting, appealing, tracking, and preventing claims that a payer doesn't pay as billed. It is a repeating cycle that runs every time a remittance comes back with less money than expected.
There's a meaningful difference between the two halves of that cycle:
- Reactive recovery fixes the claim in front of you by correcting an error, filing an appeal, chasing a reconsideration.
- Proactive prevention asks why the claim failed in the first place, then changes the upstream process so it doesn't happen again.
Practices that only do the first half stay busy forever. Practices that do both eventually see denial volume drop.
Where Denial Management Sits in the Revenue Cycle
Denial management is one piece of revenue cycle management (RCM) , the full chain from scheduling and eligibility checks through charge capture, coding, claim submission, payment posting, and patient collections. It specifically covers what happens after a claim is submitted and the payer doesn't pay it in full.
Unmanaged denials carry real costs: delayed reimbursement, staff time spent on rework, avoidable write-offs, and uncertainty when forecasting revenue.
Industry data gives a sense of scale. MGMA's 2024 report found an 8% initial denial rate across its single-specialty practice benchmark, and 60% of surveyed practice leaders said denials had increased over the prior year. That's a general physician-practice figure, not an ID-specific one, but it signals the trend is real.
Why This Hits Infectious Disease Practices Differently
In a drug-heavy specialty, a single denied infusion or antimicrobial claim can carry weeks of acquisition cost. One hard denial on a buy-and-bill drug claim can outweigh a month of office visit revenue. That's a different risk profile than a practice billing mostly E/M codes.
Denial outcomes in ID practices are shaped by:
- Prior authorization timing and reauthorization on extended courses
- Medical-necessity documentation for the antimicrobial itself
- OPAT and infusion coordination between clinical and billing staff
- Recurring-service details that need to stay current across multiple visits
An effective denial management program uses the practice's own payer mix, service lines, and denial history , not generalized industry rates or margins that don't reflect how your specific contracts and patients actually work.
What Are the Steps in the Denial Management Process?
Most frameworks describe four stages: identify, manage, monitor, and prevent. Different organizations use different labels, but the underlying work is consistent.
Identify and Capture the Denial
Start with the remittance advice or electronic explanation of benefits. Review the claim adjustment reason codes and any remark codes attached, confirm which claim line was affected, and record the payer's stated reason exactly as given. This record becomes the foundation for everything that follows.
Investigate and Classify the Root Cause
Dig into what actually went wrong:
- Patient demographics and eligibility status at time of service
- Authorization status, including whether it had expired
- Coding, modifiers, and documentation completeness
- Medical necessity, timely filing, duplicate billing, or coordination of benefits
For an ID practice, this might mean checking whether the authorization, order, or treatment documentation actually supports the billed service, without assuming authorization was always required in the first place. Payers sometimes assert authorization was missing even when it was obtained; the remittance reason isn't always the full story.
Triage, Resolve, and Monitor
Not every denial deserves the same urgency. Triage by:
- Appeal deadline: some payers give 30 days, others 90 or more
- Dollar value: a $4,000 infusion claim outranks a $120 office visit
- Likelihood of recovery: is this fixable or structurally denied?
- Whether it's correctable (resubmit) or requires justification (appeal)
Correct and resubmit administrative errors. For claims requiring justification, assemble supporting records and cite the specific coverage criterion met, rather than appealing on general medical necessity language. Document every action, date, and outcome.
Appeal windows vary by payer and plan type. For Original Medicare fee-for-service specifically, CMS's appeals guidance lists five levels: 120 days for redetermination, 180 days for reconsideration, and 60 days for each level after that. Commercial and Medicare Advantage plans run on different schedules, so confirm deadlines payer by payer rather than assuming one timeline fits all.
Monitoring closes the loop. Track denial categories monthly, assign ownership of recurring issues to the team that can actually fix them, and audit unresolved claims before deadlines pass.
What Types of Claim Denials Do Practices Encounter?
Denials generally fall into two buckets, though exact categorization varies by payer and billing system.
Administrative or front-end denials happen before clinical review:
- Inactive or incorrect coverage information
- Patient demographic mismatches
- Missing authorization or referral details
- Duplicate claims or incorrect payer routing
- Missed filing deadlines
Clinical or technical denials involve the payer's substantive review:
- Coding or modifier errors (modifier 25 is a frequent culprit)
- Diagnosis-procedure mismatches
- Insufficient documentation or medical-necessity concerns
- Bundling edits, including NCCI procedure-to-procedure rules that affect infusion hierarchy billing
For infectious disease practices specifically, common root causes include:
- Authorization that is absent or expired
- Site-of-care mismatches
- Drug unit or wastage reporting errors
- Confusion between medical and pharmacy benefit pathways
Some practitioners distinguish between a "soft" denial (correctable and resubmittable) and a "hard" denial that requires appeal or may not be recoverable at all. In a buy-and-bill model, a hard denial on a drug claim is effectively a realized inventory loss, not deferred revenue.
Definitions of soft versus hard vary by payer, so confirm current guidance rather than assuming a universal standard.
"Top denial codes" lists you'll find online vary by payer, specialty, and time period. Treat any ranked list as a starting point for investigation, not a diagnosis of your own practice's problem.
How Can an Infectious Disease Practice Prevent Claim Denials?
Prevention beats recovery every time, and it starts before the claim is ever submitted.
Front-End Accuracy
Verify eligibility and benefits for every visit, confirm demographic and insurance details are current, and document authorization and referral requirements clearly. For treatment that spans multiple visits (OPAT courses, extended infusion series), build a process to refresh this information as care continues. One of the most commonly missed, most expensive steps is reauthorization before an extended course runs out, creating a coverage gap mid-treatment.
Documentation, Coding, and Claim Review
The clinical record needs to support the diagnosis, service, treatment plan, medical necessity, and duration of care , including anything specific the payer requires. Time-based code selection, for example, requires total time on the date of the encounter, including qualifying non-face-to-face work.
Use claim-scrubbing software to catch missing fields, invalid codes, and modifier mismatches before submission. Software edits catch patterns; they don't replace a human reviewer checking whether the documentation actually matches what's billed.
Build Payer-Specific Workflows
Keep a current reference (even a simple one-page sheet per payer or per drug) covering:
- Whether authorization is required and what documentation satisfies it
- Filing deadlines and required attachments
- Appeal format and escalation contacts
Update these as payer policies change. AMA's 2025 survey of physicians found an average of 39 prior authorization requests per week and 13 hours of staff time spent on them weekly . That workload that makes a documented, repeatable process worth the setup time.
Close the Feedback Loop
Group denials by root cause, assign the fix to the team that owns it (front office, coding, or clinical documentation), and check whether the change actually reduced repeat denials. Technology can help with eligibility checks, claim-status monitoring, and worklist prioritization, but it should support staff judgment, not replace it.
GrowInfectiousDisease publishes free, ungated guidance and browser-based tools on exactly this kind of revenue-cycle question, built so practices can plug in their own payer mix and denial history rather than relying on generalized benchmarks.
How Should Practices Measure and Improve Denial Management?
You can't fix what you don't track. A handful of core measures tell most of the story:
| Metric | What it shows |
|---|---|
| Denial rate (count and dollars) | Volume and financial scale of the problem |
| Hard-denial dollars on drug claims | Realized losses, not deferred revenue |
| Days in A/R, especially over 90 days | Where authorization and drug-claim issues pile up |
| Payment variance vs. contracted rate | Underpayments that look like full payment at a glance |
Segment Before You Conclude
Break reports down by payer, provider, service line, and denial reason. A denial rate that looks fine overall can hide one payer or one service line driving most of the pain.
Be cautious with industry benchmarks. Performance varies widely by specialty, payer mix, and claim type. An aggregate figure from one specialty mix will not necessarily apply to a drug-heavy ID practice. Build your own baseline before chasing someone else's target.
A Workable Cadence
- Monthly: Track hard-denial dollars by root cause, assign one category to the process step that owns it, set a target and date
- Quarterly: Review payment variance against contracted rates on your highest-value drug claims
A small practice doesn't need advanced analytics on day one. A consistent denial log and three or four reliable metrics will outperform an elaborate dashboard nobody updates.
Conclusion
Denial management works as both a recovery process and a prevention system. Practices have to resolve the claims sitting in their queue right now while using those same denials to fix whatever's broken upstream in registration, authorization, documentation, or coding.
For an independent ID practice, the most actionable starting points are straightforward:
- Capture every denial
- Classify its root cause
- Protect appeal deadlines
- Keep clinical and billing teams talking to each other
- Review your own trends on a set schedule rather than letting the backlog grow quietly
GrowInfectiousDisease offers free, ungated resources built around infectious disease practice economics . Use them to understand how denials and reimbursement actually move through your specific practice, with your own numbers, not a generic industry average.
Frequently Asked Questions
What is denial management in healthcare?
Denial management is the process of identifying, correcting, appealing, tracking, and preventing healthcare claims that a payer doesn't pay as billed. It combines fixing individual claims with addressing the root causes behind repeat denials.
What are the steps involved in claim denial management?
The typical sequence covers identification, investigation of the root cause, prioritization by deadline and dollar value, correction or appeal, follow-up, and ongoing monitoring to prevent recurrence. Exact terminology varies between organizations.
What are the five elements of claim denial management?
Frameworks differ, but a practical five-part version includes identification, classification, resolution, tracking, and prevention. The goal across all versions is the same: stop a denial from becoming a permanent write-off.
What is RCM denial management?
Denial management is the claims-focused piece within the broader revenue cycle management process. RCM covers everything from scheduling through patient collections; denial management specifically handles what happens after a claim comes back unpaid or underpaid.
What are the three types of claim denials?
Practices commonly group denials as administrative, clinical or medical-necessity, and technical or coding-related. Classification systems vary by payer and billing software, so treat these as working categories, not fixed definitions.
What is the difference between a rejection and a denial in medical billing?
A rejection happens before adjudication: the claim fails a submission or format check and never enters payer review. A denial occurs after the payer reviews the claim and finds it isn't payable, requiring correction, reconsideration, or appeal.
